Surgical Science Sweden AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SUSRF research report →
Companywww.surgicalscience.com
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators.
- CEO
- Tom Englund
- IPO
- 2021
- Employees
- 274
- HQ
- Gothenburg, SE
Price Chart
Valuation
- Market Cap
- $208.70M
- P/E
- 28.70
- P/S
- 1.93
- P/B
- 0.45
- EV/EBITDA
- 9.92
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 63.93%
- Op Margin
- 7.64%
- Net Margin
- 6.73%
- ROE
- 1.54%
- ROIC
- 1.15%
Growth & Income
- Revenue
- $989.85M · 11.96%
- Net Income
- $66.65M · -49.37%
- EPS
- $1.29 · -50.00%
- Op Income
- $108.70M
- FCF YoY
- -24.25%
Performance & Tape
- 52W High
- $16.33
- 52W Low
- $2.84
- 50D MA
- $2.87
- 200D MA
- $5.49
- Beta
- 0.57
- Avg Volume
- 3
Get TickerSpark's AI analysis on SUSRF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SUSRF Coverage
We haven't published any research on SUSRF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SUSRF Report →